LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE was reported 61323 times

These side effects are most commonly reported by patients taking LIDOCAINE HYDROCHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 4451
1 NAUSEA 3838
2 PAIN 3749
3 FATIGUE 3654
4 HEADACHE 3425
5 OFF LABEL USE 3295
6 DYSPNOEA 2863
7 DIARRHOEA 2594
8 PNEUMONIA 2372
9 VOMITING 2320
10 DIZZINESS 2212
11 HYPOTENSION 2045
12 SINUSITIS 2019
13 PYREXIA 1998
14 FALL 1929
15 DEATH 1920
16 PRODUCT DOSE OMISSION ISSUE 1839
17 RASH 1691
18 ANXIETY 1687
19 MALAISE 1679
20 ARTHRALGIA 1659
21 URINARY TRACT INFECTION 1627
22 COUGH 1578
23 BACK PAIN 1575
24 ASTHENIA 1521
25 COVID-19 1497
26 TOXICITY TO VARIOUS AGENTS 1484
27 PAIN IN EXTREMITY 1445
28 WEIGHT DECREASED 1390
29 INFUSION SITE PAIN 1336
30 PRODUCT USE IN UNAPPROVED INDICATION 1313
31 PRURITUS 1308
32 RENAL FAILURE 1293
33 CARDIAC ARREST 1272
34 HYPERTENSION 1237
35 NASOPHARYNGITIS 1187
36 CONSTIPATION 1175
37 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1148
38 CONDITION AGGRAVATED 1103
39 DECREASED APPETITE 1086
40 ANAEMIA 1048
41 ABDOMINAL PAIN 1047
42 DRUG HYPERSENSITIVITY 1045
43 ACUTE KIDNEY INJURY 1035
44 ANAPHYLACTIC REACTION 1009
45 SOMNOLENCE 994
46 CHEST PAIN 984
47 ERYTHEMA 972
48 DRUG INTERACTION 958
49 INSOMNIA 958
50 ILLNESS 924
51 INFECTION 922
52 BRONCHITIS 908
53 DEPRESSION 905
54 CHRONIC KIDNEY DISEASE 897
55 BLOOD PRESSURE INCREASED 875
56 ANAPHYLACTIC SHOCK 869
57 SEPSIS 866
58 LOSS OF CONSCIOUSNESS 860
59 TACHYCARDIA 856
60 INFUSION SITE ERYTHEMA 855
61 CONFUSIONAL STATE 845
62 FEELING ABNORMAL 833
63 PRODUCT USE ISSUE 832
64 UPPER RESPIRATORY TRACT INFECTION 814
65 PERIPHERAL SWELLING 812
66 INFLUENZA 808
67 WEIGHT INCREASED 805
68 HYPOAESTHESIA 801
69 SEIZURE 798
70 MUSCLE SPASMS 795
71 TREMOR 790
72 HYPERSENSITIVITY 788
73 OVERDOSE 783
74 GAIT DISTURBANCE 770
75 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 770
76 BRADYCARDIA 768
77 URTICARIA 767
78 CHILLS 744
79 INJECTION SITE PAIN 730
80 DEHYDRATION 724
81 INFUSION SITE SWELLING 716
82 MIGRAINE 700
83 PARAESTHESIA 698
84 CONTUSION 695
85 FEBRILE NEUTROPENIA 686
86 STRESS 682
87 INJURY 678
88 INFUSION RELATED REACTION 677
89 ABDOMINAL PAIN UPPER 658
90 EMOTIONAL DISTRESS 658
91 OEDEMA PERIPHERAL 652
92 ATRIAL FIBRILLATION 628
93 MYALGIA 620
94 SWELLING 618
95 ABDOMINAL DISTENSION 577
96 MUSCULAR WEAKNESS 575
97 PRODUCT ADHESION ISSUE 574
98 UNEVALUABLE EVENT 573
99 OXYGEN SATURATION DECREASED 565
100 ASTHMA 562
101 ABDOMINAL DISCOMFORT 557
102 BLOOD PRESSURE DECREASED 557
103 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 549
104 OROPHARYNGEAL PAIN 548
105 RESPIRATORY FAILURE 548
106 CELLULITIS 545
107 PRODUCT QUALITY ISSUE 545
108 SYNCOPE 538
109 EAR INFECTION 537
110 NEUROPATHY PERIPHERAL 534
111 CHEST DISCOMFORT 533
112 HEART RATE INCREASED 533
113 HYPERHIDROSIS 533
114 HYPOXIA 533
115 PALPITATIONS 523
116 RESPIRATORY TRACT INFECTION 522
117 VISION BLURRED 516
118 INSURANCE ISSUE 512
119 ALOPECIA 511
120 CEREBROVASCULAR ACCIDENT 501
121 GASTROOESOPHAGEAL REFLUX DISEASE 501
122 PLATELET COUNT DECREASED 498
123 DYSPHAGIA 493
124 INTENTIONAL PRODUCT USE ISSUE 476
125 INFUSION SITE HAEMORRHAGE 472
126 DRUG INTOLERANCE 465
127 PULMONARY EMBOLISM 465
128 PLEURAL EFFUSION 464
129 GASTROINTESTINAL DISORDER 460
130 SEASONAL ALLERGY 460
131 MEMORY IMPAIRMENT 456
132 MATERNAL EXPOSURE DURING PREGNANCY 452
133 PRODUCTIVE COUGH 449
134 THERAPY NON-RESPONDER 447
135 RENAL INJURY 445
136 OEDEMA 444
137 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 443
138 NECK PAIN 442
139 HERPES ZOSTER 440
140 RENAL IMPAIRMENT 440
141 WHITE BLOOD CELL COUNT DECREASED 433
142 HAEMOGLOBIN DECREASED 432
143 INCORRECT DOSE ADMINISTERED 431
144 NEUTROPENIA 427
145 JOINT SWELLING 418
146 ANHEDONIA 417
147 GENERAL PHYSICAL HEALTH DETERIORATION 415
148 STOMATITIS 414
149 THROMBOSIS 411
150 VENTRICULAR TACHYCARDIA 410
151 THROMBOCYTOPENIA 409
152 EPISTAXIS 406
153 FLUSHING 402
154 NO ADVERSE EVENT 401
155 STAPHYLOCOCCAL INFECTION 401
156 DRY MOUTH 400
157 END STAGE RENAL DISEASE 397
158 HOSPITALISATION 395
159 HYPOKALAEMIA 390
160 ARTHRITIS 389
161 INFLUENZA LIKE ILLNESS 387
162 DERMATITIS CONTACT 386
163 VISUAL IMPAIRMENT 386
164 MUSCULOSKELETAL STIFFNESS 381
165 VIRAL INFECTION 380
166 CATARACT 377
167 FEAR 377
168 BURNING SENSATION 376
169 CARDIO-RESPIRATORY ARREST 375
170 UNRESPONSIVE TO STIMULI 375
171 DYSPEPSIA 373
172 HYPONATRAEMIA 373
173 HAEMORRHAGE 366
174 INFUSION SITE DISCHARGE 366
175 GENERALISED TONIC-CLONIC SEIZURE 363
176 BALANCE DISORDER 361
177 INFUSION SITE PRURITUS 360
178 DISCOMFORT 358
179 AGITATION 357
180 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 350
181 PULMONARY OEDEMA 348
182 EXPOSURE DURING PREGNANCY 346
183 BLOOD GLUCOSE INCREASED 342
184 MYOCARDIAL INFARCTION 342
185 VENTRICULAR FIBRILLATION 342
186 CYSTITIS 341
187 MENTAL STATUS CHANGES 339
188 INTENTIONAL PRODUCT MISUSE 332
189 DISEASE PROGRESSION 331
190 CARDIAC DISORDER 330
191 SLEEP DISORDER 330
192 DRUG ABUSE 326
193 WHEEZING 326
194 LETHARGY 325
195 NASAL CONGESTION 323
196 DYSARTHRIA 319
197 NEURALGIA 317
198 OSTEOARTHRITIS 317
199 RHEUMATOID ARTHRITIS 314
200 CARDIAC FAILURE 312
201 RHINORRHOEA 310
202 DIABETES MELLITUS 309
203 VERTIGO 305
204 DEPRESSED LEVEL OF CONSCIOUSNESS 304
205 DYSPNOEA EXERTIONAL 304
206 METHAEMOGLOBINAEMIA 301
207 MULTIPLE ALLERGIES 300
208 BLISTER 297
209 CARDIOGENIC SHOCK 296
210 ASPARTATE AMINOTRANSFERASE INCREASED 293
211 CARDIAC FAILURE CONGESTIVE 292
212 EYE PAIN 292
213 MALIGNANT NEOPLASM PROGRESSION 291
214 COMA 290
215 DEVICE ISSUE 290
216 FLUID RETENTION 290
217 NEPHROLITHIASIS 290
218 TREATMENT FAILURE 288
219 INJECTION SITE ERYTHEMA 287
220 DYSPHONIA 286
221 HALLUCINATION 283
222 ALANINE AMINOTRANSFERASE INCREASED 281
223 OSTEOPOROSIS 280
224 DEEP VEIN THROMBOSIS 276
225 GASTROINTESTINAL HAEMORRHAGE 276
226 GASTROENTERITIS VIRAL 273
227 SWELLING FACE 272
228 DELIRIUM 270
229 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 270
230 PAIN IN JAW 269
231 SPEECH DISORDER 269
232 MUSCULOSKELETAL PAIN 268
233 MULTIPLE ORGAN DYSFUNCTION SYNDROME 267
234 BLOOD CREATININE INCREASED 266
235 MEDICATION ERROR 265
236 TINNITUS 263
237 INFUSION SITE EXTRAVASATION 261
238 POST PROCEDURAL COMPLICATION 261
239 SHOCK 261
240 CONVULSION 260
241 DRY SKIN 259
242 MOBILITY DECREASED 258
243 ANGIOEDEMA 257
244 FOETAL EXPOSURE DURING PREGNANCY 257
245 RENAL FAILURE ACUTE 257
246 ARRHYTHMIA 253
247 BACTERIAL INFECTION 253
248 ELECTROCARDIOGRAM QT PROLONGED 252
249 LOWER RESPIRATORY TRACT INFECTION 252
250 BONE PAIN 249
251 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 249
252 SINUS TACHYCARDIA 249
253 AMNESIA 248
254 LUNG DISORDER 248
255 MULTI-ORGAN FAILURE 248
256 SUICIDAL IDEATION 248
257 FUNGAL INFECTION 245
258 ADVERSE DRUG REACTION 244
259 DEVICE INFUSION ISSUE 244
260 SEPTIC SHOCK 244
261 RESPIRATORY DISTRESS 243
262 LIMB INJURY 241
263 LOCALISED INFECTION 241
264 SINUS DISORDER 241
265 RESPIRATORY ARREST 240
266 STATUS EPILEPTICUS 239
267 ACCIDENTAL OVERDOSE 235
268 DEVICE DISLOCATION 235
269 METABOLIC ACIDOSIS 235
270 NEUTROPHIL COUNT DECREASED 235
271 PANCYTOPENIA 234
272 ARTHROPATHY 233
273 HEART RATE DECREASED 231
274 BLOOD CHOLESTEROL INCREASED 229
275 SKIN DISCOLOURATION 229
276 DIPLOPIA 228
277 FEELING HOT 228
278 HOT FLUSH 228
279 INFUSION SITE BRUISING 228
280 NEUROTOXICITY 226
281 ASCITES 225
282 KIDNEY INFECTION 225
283 SURGERY 225
284 NEPHROGENIC ANAEMIA 224
285 CIRCULATORY COLLAPSE 221
286 BRONCHOSPASM 220
287 ACUTE RESPIRATORY FAILURE 219
288 INFLAMMATION 219
289 SKIN EXFOLIATION 218
290 PALLOR 217
291 ROAD TRAFFIC ACCIDENT 217
292 DYSGEUSIA 216
293 RASH PRURITIC 215
294 FIBROMYALGIA 214
295 WHITE BLOOD CELL COUNT INCREASED 212
296 PREMATURE BABY 209
297 ANAESTHETIC COMPLICATION 208
298 DISTURBANCE IN ATTENTION 208
299 HAEMORRHOIDS 207
300 POOR VENOUS ACCESS 207
301 POOR QUALITY SLEEP 206
302 INJECTION SITE SWELLING 204
303 HYPERKALAEMIA 203
304 INFUSION SITE REACTION 203
305 LYMPHADENOPATHY 203
306 RESTLESSNESS 203
307 RIB FRACTURE 201
308 THERAPY INTERRUPTED 200
309 ACCIDENTAL EXPOSURE TO PRODUCT 199
310 ENCEPHALOPATHY 199
311 TOXIC ANTERIOR SEGMENT SYNDROME 199
312 DRUG DEPENDENCE 198
313 URINARY RETENTION 198
314 C-REACTIVE PROTEIN INCREASED 197
315 DYSKINESIA 196
316 INCORRECT DRUG ADMINISTRATION RATE 196
317 HYPERLIPIDAEMIA 195
318 MATERNAL EXPOSURE DURING DELIVERY 195
319 HYPOAESTHESIA ORAL 193
320 DYSURIA 192
321 HEAD INJURY 192
322 CANDIDA INFECTION 191
323 BLOOD POTASSIUM DECREASED 190
324 MYDRIASIS 190
325 COGNITIVE DISORDER 189
326 THERAPY PARTIAL RESPONDER 189
327 MENTAL DISORDER 188
328 PNEUMONIA ASPIRATION 188
329 RESPIRATORY DISORDER 188
330 SKIN DISORDER 188
331 PROCEDURAL PAIN 187
332 APHASIA 186
333 INFUSION SITE INFECTION 186
334 DIVERTICULITIS 184
335 PULMONARY HYPERTENSION 184
336 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 180
337 BLINDNESS 179
338 DISORIENTATION 179
339 URINARY INCONTINENCE 179
340 INTERVERTEBRAL DISC PROTRUSION 178
341 THROAT IRRITATION 178
342 DRY EYE 177
343 SKIN INFECTION 177
344 LIMB DISCOMFORT 176
345 TOOTH INFECTION 176
346 HAEMOPTYSIS 175
347 RECTAL HAEMORRHAGE 175
348 COLITIS 174
349 PSORIASIS 174
350 RESPIRATORY DEPRESSION 174
351 DEVICE OCCLUSION 173
352 FLATULENCE 173
353 RENAL DISORDER 173
354 SKIN ULCER 173
355 ADVERSE EVENT 172
356 NERVOUSNESS 172
357 ORAL PAIN 171
358 VISUAL ACUITY REDUCED 170
359 BODY TEMPERATURE INCREASED 169
360 LYMPHOCYTE COUNT DECREASED 169
361 THERAPEUTIC RESPONSE DECREASED 169
362 DRUG DOSE OMISSION 168
363 MUCOSAL INFLAMMATION 168
364 STRESS CARDIOMYOPATHY 168
365 HYPOTHYROIDISM 167
366 SLEEP APNOEA SYNDROME 167
367 OSTEOMYELITIS 165
368 INTENTIONAL OVERDOSE 164
369 JOINT INJURY 164
370 APNOEA 163
371 PRODUCT DISTRIBUTION ISSUE 163
372 HEPATIC ENZYME INCREASED 162
373 DEVICE MALFUNCTION 160
374 FOOT FRACTURE 160
375 INJECTION SITE BRUISING 160
376 INTESTINAL OBSTRUCTION 160
377 NERVOUS SYSTEM DISORDER 160
378 RASH ERYTHEMATOUS 160
379 LIP SWELLING 159
380 ATELECTASIS 158
381 CROHN^S DISEASE 158
382 CYANOSIS 158
383 INFUSION SITE IRRITATION 157
384 IMPAIRED HEALING 156
385 POLLAKIURIA 156
386 HYPOPHOSPHATAEMIA 155
387 RED BLOOD CELL COUNT DECREASED 155
388 SCIATICA 155
389 VENTRICULAR EXTRASYSTOLES 155
390 CHOLELITHIASIS 154
391 DEVICE LEAKAGE 154
392 NEOPLASM MALIGNANT 154
393 SWOLLEN TONGUE 154
394 CLOSTRIDIUM DIFFICILE INFECTION 153
395 BRAIN OEDEMA 152
396 HAEMATURIA 152
397 INFUSION SITE INDURATION 152
398 SEROTONIN SYNDROME 152
399 TENDERNESS 152
400 HAEMATOMA 151
401 MUSCULOSKELETAL CHEST PAIN 151
402 NIGHT SWEATS 151
403 HAEMATOCRIT DECREASED 150
404 PHARYNGITIS STREPTOCOCCAL 150
405 RESPIRATORY TRACT CONGESTION 150
406 SCAR 150
407 BONE DENSITY DECREASED 149
408 ECZEMA 149
409 IMPAIRED QUALITY OF LIFE 149
410 LEUKOPENIA 149
411 SKIN LACERATION 149
412 DRUG LEVEL INCREASED 148
413 LIVER DISORDER 147
414 MYASTHENIA GRAVIS 147
415 APPENDICITIS 146
416 COMPLETED SUICIDE 146
417 CONJUNCTIVITIS 146
418 INJECTION SITE PRURITUS 146
419 ORAL HERPES 146
420 CYTOKINE RELEASE SYNDROME 145
421 WOUND 145
422 ECONOMIC PROBLEM 144
423 INFUSION SITE WARMTH 144
424 MOUTH ULCERATION 144
425 PNEUMOTHORAX 144
426 ACUTE MYOCARDIAL INFARCTION 143
427 PHARYNGITIS 143
428 IRRITABILITY 142
429 PRESYNCOPE 142
430 SPINAL OSTEOARTHRITIS 142
431 INJECTION SITE REACTION 141
432 EYE IRRITATION 140
433 FEELING COLD 140
434 GOUT 140
435 HYPERGLYCAEMIA 140
436 MUSCLE TWITCHING 140
437 TRANSIENT ISCHAEMIC ATTACK 140
438 ALTERED STATE OF CONSCIOUSNESS 139
439 BLOOD PRESSURE ABNORMAL 138
440 DEPRESSED MOOD 138
441 HAEMATOCHEZIA 138
442 TOOTH DISORDER 138
443 EAR PAIN 137
444 GAIT INABILITY 137
445 HAEMODYNAMIC INSTABILITY 137
446 MUSCULOSKELETAL DISCOMFORT 137
447 MYOCLONUS 137
448 CORONARY ARTERY DISEASE 136
449 HYPOGLYCAEMIA 136
450 NEEDLE ISSUE 136
451 OCULAR HYPERAEMIA 136
452 TACHYPNOEA 136
453 DEVICE FAILURE 135
454 HEPATIC FUNCTION ABNORMAL 135
455 TREATMENT NONCOMPLIANCE 135
456 LEUKOCYTOSIS 134
457 SINUS BRADYCARDIA 134
458 INFUSION SITE MASS 133
459 ULCER 133
460 KOUNIS SYNDROME 132
461 PARAESTHESIA ORAL 132
462 PRODUCT ADMINISTRATION INTERRUPTED 132
463 ILL-DEFINED DISORDER 131
464 IMPAIRED GASTRIC EMPTYING 131
465 LIVE BIRTH 131
466 EYE INFECTION 130
467 HIATUS HERNIA 130
468 ORAL CANDIDIASIS 129
469 OSTEOPENIA 129
470 PERICARDIAL EFFUSION 129
471 PULSELESS ELECTRICAL ACTIVITY 129
472 APPLICATION SITE PAIN 128
473 BLOOD GLUCOSE DECREASED 128
474 INTERVERTEBRAL DISC DEGENERATION 128
475 BLOOD BILIRUBIN INCREASED 127
476 GASTRITIS 127
477 HYPOACUSIS 127
478 IRRITABLE BOWEL SYNDROME 127
479 PANCREATITIS 127
480 PANIC ATTACK 127
481 HIP FRACTURE 126
482 THERAPEUTIC RESPONSE UNEXPECTED 126
483 INCORRECT ROUTE OF DRUG ADMINISTRATION 125
484 PRODUCT DOSE OMISSION 125
485 BLOOD UREA INCREASED 124
486 BONE DISORDER 124
487 DEVICE DIFFICULT TO USE 124
488 SKIN LESION 124
489 SPINAL FRACTURE 124
490 HYPERSOMNIA 123
491 INFUSION SITE RASH 123
492 PNEUMONITIS 123
493 RASH MACULAR 122
494 ROTATOR CUFF SYNDROME 122
495 THERAPEUTIC PRODUCT EFFECT DECREASED 122
496 TOOTHACHE 122
497 BLOOD ALKALINE PHOSPHATASE INCREASED 121
498 HYPERPARATHYROIDISM SECONDARY 121
499 RHABDOMYOLYSIS 121
500 TOXIC EPIDERMAL NECROLYSIS 121
501 BRAIN FOG 120
502 ENDOPHTHALMITIS 120
503 PREMATURE DELIVERY 120
504 OSTEONECROSIS 119
505 PLASMA CELL MYELOMA 119
506 PULSE ABSENT 119
507 DRUG WITHDRAWAL SYNDROME 118
508 RASH MACULO-PAPULAR 118
509 WEIGHT FLUCTUATION 118
510 EYE DISORDER 117
511 HYPOPHAGIA 117
512 SINUS CONGESTION 117
513 DYSSTASIA 116
514 HEMIPARESIS 116
515 PARALYSIS 116
516 TUBULOINTERSTITIAL NEPHRITIS 116
517 GASTROINTESTINAL INFECTION 115
518 NERVE INJURY 115
519 THROAT TIGHTNESS 115
520 DRUG TOXICITY 114
521 HYPOCALCAEMIA 114
522 INJECTION SITE HAEMORRHAGE 114
523 LACRIMATION INCREASED 114
524 LIVER FUNCTION TEST INCREASED 114
525 CHROMATURIA 113
526 DISABILITY 113
527 DRUG EFFECT DECREASED 113
528 INFUSION SITE NODULE 113
529 SUPRAVENTRICULAR TACHYCARDIA 113
530 CARPAL TUNNEL SYNDROME 112
531 DEVICE USE ERROR 112
532 HEART RATE IRREGULAR 112
533 HYPERPHOSPHATAEMIA 112
534 PULMONARY MASS 112
535 TASTE DISORDER 111
536 BLOOD SODIUM DECREASED 110
537 CEREBRAL HAEMORRHAGE 110
538 COVID-19 PNEUMONIA 110
539 DEVICE MAINTENANCE ISSUE 110
540 EATING DISORDER 110
541 PRODUCT DOSE OMISSION IN ERROR 110
542 ANGINA PECTORIS 109
543 BLOOD PHOSPHORUS INCREASED 109
544 BLOOD URIC ACID INCREASED 109
545 CARDIOMEGALY 109
546 INTERSTITIAL LUNG DISEASE 109
547 OSTEONECROSIS OF JAW 109
548 SPINAL PAIN 109
549 TOOTH ABSCESS 109
550 HORNER^S SYNDROME 108
551 IRON DEFICIENCY 108
552 SEDATION 108
553 UPPER LIMB FRACTURE 108
554 WITHDRAWAL SYNDROME 108
555 APPLICATION SITE ERYTHEMA 107
556 MASS 107
557 PURULENT DISCHARGE 107
558 SKIN IRRITATION 107
559 SUICIDE ATTEMPT 107
560 COLD SWEAT 106
561 IMPAIRED WORK ABILITY 106
562 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 106
563 RESTLESS LEGS SYNDROME 106
564 SYSTEMIC LUPUS ERYTHEMATOSUS 106
565 AGGRESSION 105
566 BLOOD PRESSURE FLUCTUATION 105
567 DEVICE RELATED INFECTION 105
568 HALLUCINATION, VISUAL 105
569 PROCEDURAL COMPLICATION 105
570 PROCTALGIA 105
571 SNEEZING 105
572 CRYING 104
573 DECUBITUS ULCER 104
574 RENAL TUBULAR NECROSIS 104
575 ABSCESS 103
576 ACUTE RESPIRATORY DISTRESS SYNDROME 103
577 DISSEMINATED INTRAVASCULAR COAGULATION 103
578 INSPIRATORY CAPACITY DECREASED 103
579 INTENTIONAL DOSE OMISSION 103
580 OBSTRUCTIVE AIRWAYS DISORDER 103
581 TORSADE DE POINTES 103
582 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 102
583 MALNUTRITION 102
584 MOVEMENT DISORDER 102
585 RESPIRATORY SYNCYTIAL VIRUS INFECTION 102
586 SENSORY LOSS 102
587 APPENDICOLITH 101
588 BACK DISORDER 101
589 BREAST CANCER 101
590 DEAFNESS 101
591 BURSITIS 100
592 INFUSION SITE DISCOMFORT 100
593 NEOPLASM PROGRESSION 100
594 PSEUDOMONAS INFECTION 100
595 ANKLE FRACTURE 99
596 EYE SWELLING 99
597 HYPERAESTHESIA 99
598 PHOTOPHOBIA 99
599 RETCHING 99
600 APHONIA 98
601 BACTERAEMIA 98
602 BLOOD URINE PRESENT 98
603 PULMONARY ARTERIAL HYPERTENSION 98
604 SMALL INTESTINAL OBSTRUCTION 98
605 MUSCLE TIGHTNESS 97
606 PSORIATIC ARTHROPATHY 97
607 EPILEPSY 96
608 HEPATIC FAILURE 96
609 JOINT STIFFNESS 96
610 PRODUCT ADMINISTRATION ERROR 96
611 MULTIPLE SCLEROSIS RELAPSE 95
612 PULMONARY CONGESTION 95
613 TROPONIN INCREASED 95
614 ASPIRATION 94
615 BRONCHIECTASIS 94
616 FEEDING DISORDER 94
617 GLUCOSE TOLERANCE IMPAIRED 94
618 HYPOMAGNESAEMIA 94
619 INFUSION SITE DISCOLOURATION 94
620 MIOSIS 94
621 STEVENS-JOHNSON SYNDROME 94
622 GRAND MAL CONVULSION 93
623 INCONTINENCE 93
624 LOWER LIMB FRACTURE 93
625 DYSTONIA 92
626 JOINT RANGE OF MOTION DECREASED 92
627 MULTIPLE SCLEROSIS 92
628 PRODUCT AVAILABILITY ISSUE 92
629 BLOOD PRESSURE SYSTOLIC INCREASED 91
630 HERNIA 91
631 OBSTRUCTION 91
632 EYELID PTOSIS 90
633 ILEUS 90
634 IRON DEFICIENCY ANAEMIA 90
635 LIGAMENT SPRAIN 90
636 POST PROCEDURAL INFECTION 90
637 STREPTOCOCCAL INFECTION 90
638 TYPE 2 DIABETES MELLITUS 90
639 CARDIOTOXICITY 89
640 EJECTION FRACTION DECREASED 89
641 FACE OEDEMA 89
642 HEPATIC STEATOSIS 89
643 INJECTION SITE MASS 89
644 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 88
645 GLAUCOMA 88
646 SKIN ABRASION 88
647 VASCULAR DEVICE INFECTION 88
648 ACCIDENT 87
649 CARDIOMYOPATHY 87
650 FACIAL PARALYSIS 87
651 MENTAL IMPAIRMENT 87
652 MITRAL VALVE INCOMPETENCE 87
653 TENDONITIS 87
654 VAGINAL HAEMORRHAGE 87
655 ACNE 86
656 ARTHRITIS BACTERIAL 86
657 CLOSTRIDIUM DIFFICILE COLITIS 86
658 DERMATITIS 86
659 FULL BLOOD COUNT DECREASED 86
660 HYPOALBUMINAEMIA 86
661 MOTOR DYSFUNCTION 86
662 PURPURA 86
663 WOUND INFECTION 86
664 BLOOD CREATINE PHOSPHOKINASE INCREASED 85
665 HYPERVOLAEMIA 85
666 PRODUCT PRESCRIBING ISSUE 85
667 PRODUCT SUBSTITUTION ISSUE 85
668 VITREOUS FLOATERS 85
669 COAGULOPATHY 84
670 ESCHERICHIA INFECTION 84
671 SKIN BURNING SENSATION 84
672 AGEUSIA 83
673 DIZZINESS POSTURAL 83
674 EMOTIONAL DISORDER 83
675 FLANK PAIN 83
676 GALLBLADDER DISORDER 83
677 NYSTAGMUS 83
678 OBESITY 83
679 EXOSTOSIS 82
680 FACIAL PAIN 82
681 GASTRIC DISORDER 82
682 LABORATORY TEST ABNORMAL 82
683 LARYNGITIS 82
684 NODULE 82
685 VITAMIN D DEFICIENCY 82
686 AUTOIMMUNE DISORDER 81
687 DEVICE POWER SOURCE ISSUE 81
688 EOSINOPHILIA 81
689 GASTRIC ULCER 81
690 HAEMATEMESIS 81
691 INTERNATIONAL NORMALISED RATIO INCREASED 81
692 WRONG TECHNIQUE IN DRUG USAGE PROCESS 81
693 ATAXIA 80
694 DENTAL CARIES 80
695 EXPIRED PRODUCT ADMINISTERED 80
696 GENERALISED OEDEMA 80
697 NERVE COMPRESSION 80
698 QUALITY OF LIFE DECREASED 80
699 BASAL CELL CARCINOMA 79
700 CEREBRAL INFARCTION 79
701 COMPLICATION ASSOCIATED WITH DEVICE 79
702 HYPERTHERMIA MALIGNANT 79
703 INCORRECT PRODUCT ADMINISTRATION DURATION 79
704 INTRAOCULAR PRESSURE INCREASED 79
705 JOINT DISLOCATION 79
706 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 79
707 PRODUCT PREPARATION ERROR 79
708 REBOUND ACID HYPERSECRETION 79
709 THERAPEUTIC RESPONSE SHORTENED 79
710 ABNORMAL BEHAVIOUR 78
711 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 78
712 BLOOD TEST ABNORMAL 78
713 CHRONIC SINUSITIS 78
714 HEAD DISCOMFORT 78
715 LACTIC ACIDOSIS 78
716 NEUTROPHIL COUNT INCREASED 78
717 OTITIS MEDIA 78
718 PSYCHOTIC DISORDER 78
719 PULMONARY FIBROSIS 78
720 BUNDLE BRANCH BLOCK LEFT 77
721 DRUG ERUPTION 77
722 LEFT VENTRICULAR DYSFUNCTION 77
723 MUSCLE STRAIN 77
724 POST PROCEDURAL HAEMORRHAGE 77
725 SKIN CANCER 77
726 SPINAL OPERATION 77
727 CONCUSSION 76
728 CORNEAL OEDEMA 76
729 HEREDITARY ANGIOEDEMA 76
730 NIGHTMARE 76
731 PHARYNGEAL SWELLING 76
732 TRICUSPID VALVE INCOMPETENCE 76
733 ANAL INCONTINENCE 75
734 BLOOD POTASSIUM INCREASED 75
735 DRUG ADMINISTRATION ERROR 75
736 LUNG INFILTRATION 75
737 MICTURITION URGENCY 75
738 PERICARDITIS 75
739 PNEUMONIA BACTERIAL 75
740 TYPE I HYPERSENSITIVITY 75
741 BLOOD CALCIUM DECREASED 74
742 BODY HEIGHT DECREASED 74
743 DEMENTIA 74
744 FOOD ALLERGY 74
745 JOINT EFFUSION 74
746 METASTASES TO BONE 74
747 PARAPLEGIA 74
748 RENAL CYST 74
749 SKIN NECROSIS 74
750 TOOTH LOSS 74
751 ACTIVITIES OF DAILY LIVING IMPAIRED 73
752 ARTHRITIS INFECTIVE 73
753 DEVICE BREAKAGE 73
754 THERAPY CESSATION 73
755 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 72
756 ELECTROLYTE IMBALANCE 72
757 GAMMA-GLUTAMYLTRANSFERASE INCREASED 72
758 HYPERCHOLESTEROLAEMIA 72
759 MUSCLE RIGIDITY 72
760 RASH PAPULAR 72
761 SPINAL COMPRESSION FRACTURE 72
762 ARTHROPOD BITE 71
763 BACK INJURY 71
764 OESOPHAGITIS 71
765 PREGNANCY 71
766 ANALGESIC THERAPY 70
767 ATRIOVENTRICULAR BLOCK COMPLETE 70
768 BLOOD IRON DECREASED 70
769 CAUDA EQUINA SYNDROME 70
770 CYST 70
771 DERMATITIS ALLERGIC 70
772 EMPHYSEMA 70
773 MENINGITIS 70
774 PELVIC PAIN 70
775 PHOTOSENSITIVITY REACTION 70
776 RALES 70
777 TRANSAMINASES INCREASED 70
778 UNDERDOSE 70
779 BLOOD ALBUMIN DECREASED 69
780 BLOOD CALCIUM INCREASED 69
781 BLOOD TRIGLYCERIDES INCREASED 69
782 CONTRAINDICATED PRODUCT ADMINISTERED 69
783 DEVICE PHYSICAL PROPERTY ISSUE 69
784 DEVICE WIRELESS COMMUNICATION ISSUE 69
785 FEMUR FRACTURE 69
786 HYPERTENSIVE CRISIS 69
787 LARYNGEAL OEDEMA 69
788 LUNG INFECTION 69
789 MENINGITIS ASEPTIC 69
790 MYOCARDIAL ISCHAEMIA 69
791 PRODUCT STORAGE ERROR 69
792 SENSITIVE SKIN 69
793 UPPER-AIRWAY COUGH SYNDROME 69
794 ABDOMINAL PAIN LOWER 68
795 BRAIN INJURY 68
796 DRUG THERAPY 68
797 ECCHYMOSIS 68
798 HEPATIC CIRRHOSIS 68
799 SLEEP DISORDER THERAPY 68
800 THYROID DISORDER 68
801 AORTIC STENOSIS 67
802 BLADDER DISORDER 67
803 BONE MARROW FAILURE 67
804 DISEASE RECURRENCE 67
805 INFUSION SITE INFLAMMATION 67
806 INFUSION SITE URTICARIA 67
807 MELAENA 67
808 PRE-EXISTING CONDITION IMPROVED 67
809 PROCEDURAL HYPOTENSION 67
810 WRIST FRACTURE 67
811 DRUG EFFECT INCOMPLETE 66
812 EYE PRURITUS 66
813 GLOSSODYNIA 66
814 INADEQUATE ANALGESIA 66
815 RETINAL HAEMORRHAGE 66
816 RHINOVIRUS INFECTION 66
817 ANAESTHETIC COMPLICATION NEUROLOGICAL 65
818 GINGIVAL BLEEDING 65
819 MYELOSUPPRESSION 65
820 NEPHROPATHY 65
821 SPINAL DISORDER 65
822 SPUTUM DISCOLOURED 65
823 VENTRICULAR ARRHYTHMIA 65
824 DERMATITIS ATOPIC 64
825 FOOT DEFORMITY 64
826 HYPOKINESIA 64
827 LUNG OPACITY 64
828 MUSCULOSKELETAL DISORDER 64
829 NORMAL NEWBORN 64
830 RASH GENERALISED 64
831 RESPIRATORY ACIDOSIS 64
832 SYNOVITIS 64
833 TOOTH FRACTURE 64
834 VENTRICULAR HYPOKINESIA 64
835 WRONG PRODUCT ADMINISTERED 64
836 CARDIOVASCULAR DISORDER 63
837 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 63
838 HAND FRACTURE 63
839 ORAL DISORDER 63
840 PERIPHERAL COLDNESS 63
841 POISONING 63
842 PULMONARY THROMBOSIS 63
843 SENSORY DISTURBANCE 63
844 VASOPLEGIA SYNDROME 63
845 BENIGN PROSTATIC HYPERPLASIA 62
846 DEAFNESS NEUROSENSORY 62
847 EXTRA DOSE ADMINISTERED 62
848 HEPATOMEGALY 62
849 LIVER INJURY 62
850 LYMPHOEDEMA 62
851 ORTHOSTATIC HYPOTENSION 62
852 PERIPHERAL VASCULAR DISORDER 62
853 PSYCHOMOTOR HYPERACTIVITY 62
854 RETINAL DETACHMENT 62
855 DRUG EFFECT LESS THAN EXPECTED 61
856 DRUG-INDUCED LIVER INJURY 61
857 FULL BLOOD COUNT ABNORMAL 61
858 GROIN PAIN 61
859 HOSPICE CARE 61
860 MUSCLE ATROPHY 61
861 PARANOIA 61
862 SARS-COV-2 TEST POSITIVE 61
863 SKIN REACTION 61
864 UNINTENTIONAL MEDICAL DEVICE REMOVAL 61
865 UROSEPSIS 61
866 ARTERIOSCLEROSIS 60
867 BODY TINEA 60
868 COLITIS ULCERATIVE 60
869 INABILITY TO AFFORD MEDICATION 60
870 SUBARACHNOID HAEMORRHAGE 60
871 THIRST 60
872 BLOOD LACTATE DEHYDROGENASE INCREASED 59
873 BREATH SOUNDS ABNORMAL 59
874 DRUG EXPOSURE DURING PREGNANCY 59
875 HAEMOGLOBIN INCREASED 59
876 HYPOTONIA 59
877 INFECTION SUSCEPTIBILITY INCREASED 59
878 LUNG NEOPLASM MALIGNANT 59
879 MOOD ALTERED 59
880 OPHTHALMOPLEGIA 59
881 PRODUCT LEAKAGE 59
882 PYELONEPHRITIS 59
883 BLOOD MAGNESIUM DECREASED 58
884 CANCER PAIN 58
885 DEVICE ALARM ISSUE 58
886 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 58
887 FREQUENT BOWEL MOVEMENTS 58
888 MUSCLE SPASTICITY 58
889 POSTOPERATIVE WOUND INFECTION 58
890 PRODUCT PHYSICAL ISSUE 58
891 PRODUCT USE COMPLAINT 58
892 RHINITIS 58
893 STAPHYLOCOCCAL SEPSIS 58
894 TENDON RUPTURE 58
895 TOOTH EXTRACTION 58
896 ACUTE PULMONARY OEDEMA 57
897 ADRENAL INSUFFICIENCY 57
898 APPLICATION SITE RASH 57
899 BEDRIDDEN 57
900 CHOLECYSTITIS 57
901 DIVERTICULUM 57
902 EYE MOVEMENT DISORDER 57
903 FAECES DISCOLOURED 57
904 HAIR COLOUR CHANGES 57
905 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 57
906 RENAL PAIN 57
907 RESPIRATORY TRACT INFECTION VIRAL 57
908 SECRETION DISCHARGE 57
909 SPINAL CORD COMPRESSION 57
910 SUBDURAL HAEMATOMA 57
911 VARICOSE VEIN 57
912 APHTHOUS ULCER 56
913 APPLICATION SITE PRURITUS 56
914 CATHETER SITE PAIN 56
915 HYPERCAPNIA 56
916 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 56
917 OCULAR DISCOMFORT 56
918 PRESCRIBED OVERDOSE 56
919 PROTEINURIA 56
920 RETINAL ARTERY OCCLUSION 56
921 SKIN WARM 56
922 AGRANULOCYTOSIS 55
923 CENTRAL NERVOUS SYSTEM LESION 55
924 EYE INFLAMMATION 55
925 FOETAL EXPOSURE DURING DELIVERY 55
926 FOOD POISONING 55
927 JAUNDICE 55
928 LIVER FUNCTION TEST ABNORMAL 55
929 LUMBAR SPINAL STENOSIS 55
930 NEOPLASM 55
931 RENAL FAILURE CHRONIC 55
932 RESPIRATION ABNORMAL 55
933 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 55
934 ARTERIOSCLEROSIS CORONARY ARTERY 54
935 BLOOD LACTIC ACID INCREASED 54
936 CAESAREAN SECTION 54
937 GINGIVAL PAIN 54
938 HYPERTHYROIDISM 54
939 INHIBITORY DRUG INTERACTION 54
940 KNEE ARTHROPLASTY 54
941 LACERATION 54
942 PHARYNGEAL OEDEMA 54
943 RHINITIS ALLERGIC 54
944 RIGHT VENTRICULAR FAILURE 54
945 SUBSTANCE ABUSE 54
946 TRISMUS 54
947 ATRIOVENTRICULAR BLOCK 53
948 BLINDNESS TRANSIENT 53
949 COORDINATION ABNORMAL 53
950 DIVERTICULUM INTESTINAL 53
951 FLUID OVERLOAD 53
952 HYPERKERATOSIS 53
953 MACULAR DEGENERATION 53
954 MOUTH HAEMORRHAGE 53
955 MULTIPLE FRACTURES 53
956 PAIN OF SKIN 53
957 PARKINSON^S DISEASE 53
958 PRODUCT PRESCRIBING ERROR 53
959 RESPIRATORY RATE INCREASED 53
960 SPINAL COLUMN STENOSIS 53
961 UPPER GASTROINTESTINAL HAEMORRHAGE 53
962 ATRIAL FLUTTER 52
963 EXTRAPYRAMIDAL DISORDER 52
964 GINGIVITIS 52
965 HAIR TEXTURE ABNORMAL 52
966 HORDEOLUM 52
967 HYDRONEPHROSIS 52
968 HYPERURICAEMIA 52
969 IMMUNE SYSTEM DISORDER 52
970 MASTOIDITIS 52
971 MIDDLE INSOMNIA 52
972 OROPHARYNGEAL DISCOMFORT 52
973 SCRATCH 52
974 TOXIC SKIN ERUPTION 52
975 ANAL ABSCESS 51
976 ANAPHYLACTOID REACTION 51
977 DELAYED RECOVERY FROM ANAESTHESIA 51
978 EAR DISCOMFORT 51
979 ELECTROCARDIOGRAM ABNORMAL 51
980 ERYTHEMA MULTIFORME 51
981 FEELING JITTERY 51
982 HEPATITIS 51
983 HICCUPS 51
984 IMMUNODEFICIENCY 51
985 METASTASES TO CENTRAL NERVOUS SYSTEM 51
986 METASTASES TO LUNG 51
987 ORAL DISCOMFORT 51
988 PARADOXICAL DRUG REACTION 51
989 POST-TRAUMATIC STRESS DISORDER 51
990 SKIN HAEMORRHAGE 51
991 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 51
992 STRIDOR 51
993 ACUTE CORONARY SYNDROME 50
994 ACUTE MYELOID LEUKAEMIA 50
995 BLOOD PRESSURE DIASTOLIC DECREASED 50
996 FAILURE TO THRIVE 50
997 HEPARIN-INDUCED THROMBOCYTOPENIA 50
998 LOW BIRTH WEIGHT BABY 50
999 MONOPLEGIA 50